4.6 Article

Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis

Journal

THORAX
Volume 76, Issue 7, Pages 714-722

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2020-216422

Keywords

sleep apnoea; oxidative stress

Funding

  1. Zoe Global Limited
  2. Wellcome Trust [212904/Z/18/Z]
  3. Medical Research Council (MRC)/British Heart Foundation Ancestry and Biological Informative Markers for Stratification of Hypertension (AIMHY) [MR/M016560/1]
  4. Wellcome Trust
  5. Medical Research Council
  6. European Union
  7. Chronic Disease Research Foundation (CDRF)
  8. Zoe Global Ltd.
  9. National Institute for Health Research (NIHR)
  10. King's College London
  11. Medical Research Council [MR/M004422/1]
  12. BREATHE - The Health Data Research Hub for Respiratory Health [MC_PC_19004]
  13. UK Research and Innovation Industrial Strategy Challenge Fund
  14. MRC [MR/M004422/1] Funding Source: UKRI

Ask authors/readers for more resources

This study found that sleep apnoea associated hypoxia and very short sleep may be associated with an increased prevalence of moderate-to-severe CKD. This indicates that sleep may have a certain impact on the development of CKD.
Background Poor sleep may contribute to chronic kidney disease (CKD) through several pathways, including hypoxia-induced systemic and intraglomerular pressure, inflammation, oxidative stress and endothelial dysfunction. However, few studies have investigated the association between multiple objectively measured sleep dimensions and CKD. Methods We investigated the cross-sectional association between sleep dimensions and CKD among 1895 Multi-Ethnic Study of Atherosclerosis Sleep Ancillary Study participants who completed in-home polysomnography, wrist actigraphy and a sleep questionnaire. Using Poisson regression models with robust variance, we estimated separate prevalence ratios (PR) and 95% CIs for moderate-to-severe CKD (glomerular filtration rate 30 mg/g) among participants according to multiple sleep dimensions, including very short (<= 5 hours) sleep, Apnoea-Hypopnoea Index and sleep apnoea-specific hypoxic burden (SASHB) (total area under the respiratory event-related desaturation curve divided by total sleep duration, %min/hour)). Regression models were adjusted for sociodemographic characteristics, health behaviours and clinical characteristics. Results Of the 1895 participants, mean age was 68.2 +/- 9.1 years, 54% were women, 37% were white, 28% black, 24% Hispanic/Latino and 11% Asian. Several sleep metrics were associated with higher adjusted PR of moderate-to-severe CKD: very short versus recommended sleep duration (PR=1.40, 95% CI 1.06 to 1.83); SASHB (Box-Cox transformed SASHB: PR=1.06, 95% CI 1.02 to 1.12); and for participants in the highest quintile of SASHB plus sleep apnoea: PR=1.28, 95% CI 1.01 to 1.63. Conclusions Sleep apnoea associated hypoxia and very short sleep, likely representing independent biological mechanisms, were associated with a higher moderate-to-severe CKD prevalence, which highlights the potential role for novel interventions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available